These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 15678388

  • 1. [Oncogenic osteomalacia in a 49-year-old female patient].
    Ludwig J, Mechtersheimer G, Haberkorn U, Nawroth P, Schilling T, Kasperk C.
    Dtsch Med Wochenschr; 2005 Feb 04; 130(5):206-9. PubMed ID: 15678388
    [Abstract] [Full Text] [Related]

  • 2. Tumour-induced osteomalacia: a literature review and a case report.
    Dadoniene J, Miglinas M, Miltiniene D, Vajauskas D, Seinin D, Butenas P, Kacergius T.
    World J Surg Oncol; 2016 Jan 08; 14(1):4. PubMed ID: 26744291
    [Abstract] [Full Text] [Related]

  • 3. [Oncogenic hypophosphatemic osteomalacia].
    Schultze G, Delling G, Faensen M, Haubold R, Loy V, Molzahn M, Pommer W, Semler J, Trempenau B.
    Dtsch Med Wochenschr; 1989 Jul 07; 114(27):1073-8. PubMed ID: 2737097
    [Abstract] [Full Text] [Related]

  • 4. [Hypophosphatemic oncogenic osteomalacia].
    Mátyus J, Szebenyi B, Rédl P, Mikita J, Gáspár L, Haris A, Radó J, Kakuk G.
    Orv Hetil; 2000 Dec 17; 141(51):2785-8. PubMed ID: 11196239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bone densitometry in a patient with hypophosphatemic osteomalacia.
    Negri AL, Bogado CE, Zanchetta JR.
    J Bone Miner Metab; 2004 Dec 17; 22(5):514-7. PubMed ID: 15316875
    [Abstract] [Full Text] [Related]

  • 7. Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.
    Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.
    Eur J Endocrinol; 2008 Feb 17; 158(2):265-71. PubMed ID: 18230836
    [Abstract] [Full Text] [Related]

  • 8. [Hypophosphatemic osteomalacia in adults].
    Löhr-Schwaab S, Wanner C, Reinbold WD, Schümichen C, Schölmerich J, Schaefer HE, Gerok W.
    Dtsch Med Wochenschr; 1989 Apr 07; 114(14):538-42. PubMed ID: 2702931
    [Abstract] [Full Text] [Related]

  • 9. Tumor-induced hypophosphatemic osteomalacia associated with tertiary hyperparathyroidism: a case report.
    Tartaglia F, Minisola S, Sgueglia M, Blasi S, Brunelli D, Degli Effetti E, Maturo A, Cola A, Custureri F, Campana FP.
    G Chir; 2006 Apr 07; 27(1-2):9-13. PubMed ID: 16608626
    [Abstract] [Full Text] [Related]

  • 10. Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.
    Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK.
    Clin Endocrinol (Oxf); 2001 Apr 07; 54(4):551-4. PubMed ID: 11318793
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oncogenic osteomalacia cured by removal of an organized hematoma.
    Colt E, Gopan T, Chong HS.
    Endocr Pract; 2005 Apr 07; 11(3):190-3. PubMed ID: 16239206
    [Abstract] [Full Text] [Related]

  • 13. Oncogenic osteomalacia should be considered in hypophosphatemia, bone pain and pathological fractures.
    Kaniuka-Jakubowska S, Biernat W, Lewczuk A, Świątkowska-Stodulska R, Sworczak K.
    Endokrynol Pol; 2012 Apr 07; 63(3):234-8. PubMed ID: 22744630
    [Abstract] [Full Text] [Related]

  • 14. Phosphaturic mesenchymal tumor, mixed connective tissue variant (oncogenic osteomalacia).
    Tsujimura T, Sakaguchi K, Aozasa K.
    Pathol Int; 1996 Mar 07; 46(3):238-41. PubMed ID: 10846577
    [Abstract] [Full Text] [Related]

  • 15. Somatic mutations of the MEN1 gene and microsatellite instability in a case of tertiary hyperparathyroidism occurring during high phosphate therapy for acquired, hypophosphatemic osteomalacia.
    Sato K, Obara T, Yamazaki K, Kanbe M, Nakajima K, Yamada A, Yanagisawa T, Kato Y, Nishikawa T, Takano K.
    J Clin Endocrinol Metab; 2001 Nov 07; 86(11):5564-71. PubMed ID: 11701736
    [Abstract] [Full Text] [Related]

  • 16. [Hypophosphatemic osteomalacia].
    Bullmann C, Benker G, Rosien U, Delling G, Siggelkow H, Schulte HM.
    Med Klin (Munich); 2008 Sep 15; 103(9):671-5. PubMed ID: 18813890
    [Abstract] [Full Text] [Related]

  • 17. Case report. Tumour-induced osteomalacia in a patient with osseous haemangioma.
    Lui CY, Khoo R, Law TC, Chong SF.
    Clin Radiol; 2002 Dec 15; 57(12):1125-7. PubMed ID: 12475540
    [No Abstract] [Full Text] [Related]

  • 18. Challenging case of tumour-induced osteomalacia.
    Kumar P, Jadhav DV, Ravat SH, Jain N.
    BMJ Case Rep; 2022 May 19; 15(5):. PubMed ID: 35589273
    [Abstract] [Full Text] [Related]

  • 19. Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery.
    Harbeck B, Schöcklmann H, Seekamp A, Czech N, Mönig H.
    J Clin Rheumatol; 2009 Feb 19; 15(1):31-4. PubMed ID: 19125132
    [Abstract] [Full Text] [Related]

  • 20. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment].
    Ermolenko VM, Melikaian AM, Shotemor ShSh, Potapova AV.
    Ter Arkh; 1995 Feb 19; 67(5):58-61. PubMed ID: 7638783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.